Targeting GLUT1 in acute myeloid leukemia to overcome cytarabine resistance.

Targeting GLUT1 in acute myeloid leukemia to overcome cytarabine resistance. Haematologica. 2020 Jun 18;: Authors: Åbacka H, Hansen JS, Huang P, Venskutonytė R, Hyrenius-Wittsten A, Poli G, Tuccinardi T, Granchi C, Minutolo F, Hagström-Andersson AK, Lindkvist-Petersson K PMID: 32554563 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/32554563?dopt=Abstract

Source: Haematologica - June 17, 2020 Category: Hematology Authors: Åbacka H, Hansen JS, Huang P, Venskutonytė R, Hyrenius-Wittsten A, Poli G, Tuccinardi T, Granchi C, Minutolo F, Hagström-Andersson AK, Lindkvist-Petersson K Tags: Haematologica Source Type: research

More News: Acute Leukemia | Acute Myeloid Leukemia | Hematology | Leukemia